Paper
0
The antidepressant-like effect and proposed mechanism of action of TPN672MA, a novel serotonin-dopamine receptor modulator for the treatment of schizophrenia
Authors
Published
Jun 25, 2024
Show more
Save
Tip0
TipSave
Abstract
TPN672MA, an innovative antipsychotic drug candidate currently in clinical trials, acts as a dopamine D
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.